Regal Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Regal Investment Advisors's NVS Position: Q1 2026 in Review
Regal Investment Advisors increased its Novartis (NVS) stake by 5.4% in Q1 2026, buying an estimated $41.7K and bringing the position to 5,322 shares worth $813K. The position accounts for 0.05% of the portfolio, ranked #332.
Regal Investment Advisors first reported a position in NVS in Q2 2014 and has held it in 18 quarters since. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Regal Investment Advisors held 5,322 shares of Novartis worth $813K as of Q1 2026.
- Regal Investment Advisors bought 272 Novartis shares in Q1 2026, an estimated $41.7K.
- Novartis made up 0.05% of Regal Investment Advisors's portfolio in Q1 2026, its #332 holding.
- Regal Investment Advisors first reported a position in Novartis in Q2 2014 and has held it in 18 quarters since.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Regal Investment Advisors's 13F filing for Q1 2026, filed 14 May 2026.